Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "AI"

5588 News Found

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
Digitisation | April 30, 2024

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development

New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)


Apollo HealthCo to raise Rs. 2,475 crore from Advent International
News | April 28, 2024

Apollo HealthCo to raise Rs. 2,475 crore from Advent International

Keimed is a leading wholesale pharma distribution with industry leading operating metrics


Akums launches Bharosa campaign
News | April 22, 2024

Akums launches Bharosa campaign

The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry


Vertex announces advancements of Suzetrigine in acute and neuropathic pain
News | April 22, 2024

Vertex announces advancements of Suzetrigine in acute and neuropathic pain

Breakthrough Therapy designation for pain associated with DPN granted by FDA


Fresenius Kabi USA flies complaint against NATCO Pharma
News | April 19, 2024

Fresenius Kabi USA flies complaint against NATCO Pharma

Natco Pharma intends to defend the matter accordingly


AIC-CCMB signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India
News | April 19, 2024

AIC-CCMB signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India

Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform


Jubilant Pharmova’s Roorkee unit gets VAI status
Drug Approval | April 18, 2024

Jubilant Pharmova’s Roorkee unit gets VAI status

FDA has concluded that this inspection is 'closed'


AbbVie announces late-breaking data at AAN supporting efficacy of Atogepant for preventive treatment of migraine
Diagnostic Center | April 17, 2024

AbbVie announces late-breaking data at AAN supporting efficacy of Atogepant for preventive treatment of migraine

Interim analysis of an ongoing 156-week extension study supports long-term safety, tolerability and efficacy of atogepant 60 mg to prevent chronic and episodic migraine


Teva confirms efficacy and safety of Ajovy for prevention of migraine
Diagnostic Center | April 15, 2024

Teva confirms efficacy and safety of Ajovy for prevention of migraine

Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month


Generics gain ground, yet HCPs still favor branded drugs, finds GlobalData
News | April 12, 2024

Generics gain ground, yet HCPs still favor branded drugs, finds GlobalData

A significant proportion of healthcare professionals still tend to favor branded drugs